By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > CNS stimulants > Dextroamphetamine > Dextroamphetamine Dosage
CNS stimulants
https://themeditary.com/dosage-information/dextroamphetamine-dosage-285.html

Dextroamphetamine Dosage

Drug Detail:Dextroamphetamine (Dextroamphetamine [ dex-tro-am-fet-a-meen ])

Drug Class: CNS stimulants

Contents
Uses Warnings Before Taking Dosage Side effects Interactions FAQ

Usual Adult Dose for Narcolepsy

  • Initial Dose: 10 mg orally per day
  • Maintenance Dose: May raise daily dose in 10 mg increments at weekly intervals until optimal response is obtained.

Comments:
  • The usual dose is 5 to 60 mg per day in divided doses, depending on the individual patient response.
  • IR: Give the first dose on awakening; give 1 to 2 additional doses at intervals of 4 to 6 hours.
  • ER/SR: May use this formulation for once-a-day dosage wherever appropriate.

Use: Narcolepsy treatment

Usual Pediatric Dose for Attention Deficit Disorder

Immediate-Release (IR):
Age 3 to 5 Years:

  • Initial Dose: 2.5 mg orally per day
  • Maintenance Dose: May raise daily dose in 2.5 mg increments at weekly intervals until optimal response is obtained.

IR and Extended-Release (ER)/Sustained-Release (SR):
Age 6 to 17 Years:
  • Initial Dose: 5 mg orally 1 or 2 times a day
  • Maintenance Dose: May raise daily dose in 5 mg increments at weekly intervals until optimal response is obtained.
  • Maximum Dose: Only in rare cases will it be necessary to exceed 40 mg per day.

Comments:
  • IR: Give the first dose on awakening; give 1 to 2 additional doses at intervals of 4 to 6 hours.
  • ER/SR: May use this formulation for once-a-day dosage wherever appropriate.
  • Where possible, occasionally interrupt drug administration to determine if continued therapy is required.

Use: As part of a total treatment program for Attention Deficit Hyperactivity Disorder (ADHD).

Usual Pediatric Dose for Narcolepsy

Age 6 to 11 Years:

  • Initial Dose: 5 mg orally per day
  • Maintenance Dose: May raise daily dose in 5 mg increments at weekly intervals until optimal response is obtained.

Age 12 Years and Older:
  • Initial Dose: 10 mg orally per day
  • Maintenance Dose: May raise daily dose in 10 mg increments at weekly intervals until optimal response is obtained.

Comments:
  • The usual dose is 5 to 60 mg per day in divided doses, depending on the individual patient response.
  • IR: Give the first dose on awakening; give 1 to 2 additional doses at intervals of 4 to 6 hours.
  • ER/SR: May use this formulation for once-a-day dosage wherever appropriate.
  • Narcolepsy rarely occurs in children under 12 years of age.

Use: Narcolepsy treatment

Renal Dose Adjustments

Data not available.

Liver Dose Adjustments

Data not available.

Dose Adjustments

Narcolepsy Patients: Reduce dosage if bothersome adverse reactions (e.g., insomnia, anorexia) appear.

Precautions

US BOXED WARNINGS:

  • Due to the high abuse potential, this drug should be prescribed/dispensed sparingly and particular attention should be paid to subjects possibly obtaining this drug for non-therapeutic use or distribution to others.
  • Administering this drug for prolonged periods of time should be avoided as it may lead to drug dependence.
  • Drug misuse may cause sudden death and serious cardiovascular adverse events.

Long-term effects of amphetamines in children have not been well established.
  • For ADHD treatment, the IR formulations are not recommended in patients younger than 3 years and the ER/SR formulation is not recommended in patients younger than 6 years.
  • For narcolepsy treatment, all formulations of this drug are not recommended in patients younger than 6 years.

Consult WARNINGS section for additional precautions.

US Controlled Substance: Schedule II

Dialysis

Data not available.

Other Comments

Administration Advice:

  • Avoid late evening doses because of the potential for insomnia.
  • Administer this drug at the lowest effective dosage, and individually adjust dosage.
  • Take tablet doses at the same times on each day preferably with or immediately after meals.

Storage Requirements:
  • Store this drug between 20 to 25 degrees Celsius (68 to 77 Fahrenheit) and dispense in a tight, light-resistant container.

General:
  • Individual patient response to amphetamines varies widely: toxic symptoms can occur at doses as low as 2 mg but are rare with doses of less than 15 mg; 30 mg can produce severe reactions yet doses of 400 to 500 mg are not necessarily fatal.
  • Overdosage: Management is largely symptomatic and may include gastric lavage, activated charcoal, a cathartic, and sedation; insufficient data is available to recommend the use of hemodialysis or peritoneal dialysis.

Monitoring:
  • Cardiovascular: Blood pressure, heart rate, changes in fingers and toes
  • General: Signs of abuse/dependence
  • Musculoskeletal: Growth (height, weight, appetite)
  • Psychiatric: New or worsening psychiatric disorders, including aggressive behavior/hostility, depression, psychosis, mania, and suicidal thoughts or behavior

Patient Advice:
  • Avoid driving and other potentially dangerous activities such as operating machinery until you know how this drug affects you.
  • Contact your healthcare provider if you experience any of the following on your fingers or toes during treatment: unexplained wounds, new numbness, pain, skin color change, or temperature sensitivity.

Frequently asked questions

  • Concerta vs Adderall - What's the difference between them?
  • 'Black Beauties' capsules in the 1970's - What drug was that?
  • What pill has a half moon and 26 On same side. orange,and round?
Share this Article
Latest News
Medical News

Seed oils: Omega-6 fatty acids may lower diabetes, heart disease risk

Jun 01, 2025
Type 2 diabetes: Sugary drinks may significantly raise risk
COVID-19: Who do the new vaccine guideline changes affect?
Vitamin D supplements may help slow down aging by 3 years
Aging: Exercise timing, consistency can affect heart and lung fitness
Heart health: Exercise not enough to offset effects of poor sleep
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by